Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹93Cr
Rev Gr TTM
Revenue Growth TTM
21.44%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

INDRANIB
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 185.5 | 65.1 | -3.8 | -15.0 | -9.9 | -25.5 | -23.8 | -55.7 | 13.9 | -7.7 | 16.7 | 102.1 |
| 46 | 40 | 33 | 36 | 34 | 26 | 23 | 14 | 53 | 30 | 34 | 32 |
Operating Profit Operating ProfitCr |
| 6.4 | 6.0 | 18.1 | 8.8 | 22.9 | 19.0 | 23.8 | 16.9 | -5.7 | -1.8 | 6.8 | 7.9 |
Other Income Other IncomeCr | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 1 | 2 | 1 |
Interest Expense Interest ExpenseCr | 2 | 2 | 1 | 1 | 6 | 1 | 1 | 1 | -2 | 2 | 2 | 2 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 4 | 3 | 1 | 10 | 1 | 1 | 1 |
| 2 | 0 | 6 | 1 | 5 | 1 | 1 | 0 | -8 | 0 | 1 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -10.6 | -125.1 | 5.3 | -68.6 | 228.5 | 288.9 | -78.0 | -67.6 | -280.3 | -81.2 | -25.4 | -65.7 |
| 2.9 | -1.1 | 13.7 | 2.8 | 10.7 | 2.7 | 4.0 | 2.0 | -16.9 | 0.6 | 2.5 | 0.3 |
| 0.3 | -0.1 | 1.0 | 0.2 | 0.6 | 0.1 | 0.1 | 0.1 | -1.6 | 0.0 | 0.1 | 0.0 |
| Financial Year | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 47.7 | | -57.7 | 192.0 | 164.6 | 2.0 | -21.7 | 15.7 |
| 39 | 58 | 47 | 26 | 55 | 146 | 143 | 124 | 149 |
Operating Profit Operating ProfitCr |
| 1.8 | 0.7 | 5.6 | -23.5 | 11.0 | 10.6 | 14.1 | 4.8 | 1.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | -4 | 0 | 4 | 1 | 3 | 6 |
Interest Expense Interest ExpenseCr | 0 | 0 | 1 | 2 | 2 | 6 | 10 | 12 | 5 |
Depreciation DepreciationCr | 0 | 0 | 1 | 0 | 1 | 3 | 4 | 3 | 13 |
| 0 | 0 | 1 | -11 | 4 | 12 | 11 | -6 | -7 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
|
| | -39.9 | | -1,489.0 | 139.6 | 168.7 | -12.6 | -158.6 | -20.2 |
| -0.1 | -0.1 | 1.6 | -53.2 | 7.2 | 7.3 | 6.3 | -4.7 | -4.9 |
| 0.0 | 0.0 | 0.3 | -6.0 | 1.4 | 2.8 | 1.5 | -0.4 | -1.4 |
| Financial Year | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 4 | 4 | 34 | 34 | 34 | 46 | 46 | 46 |
| 0 | 0 | -3 | -15 | -10 | 10 | 18 | 23 | 30 |
Current Liabilities Current LiabilitiesCr | 6 | 9 | 14 | 12 | 19 | 72 | 87 | 102 | 70 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 7 | 8 | 7 | 36 | 71 | 65 | 101 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 4 | 7 | 19 | 9 | 19 | 78 | 145 | 178 | 184 |
Non Current Assets Non Current AssetsCr | 6 | 6 | 32 | 31 | 32 | 78 | 89 | 90 | 91 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | 2 | 6 | 0 | 4 | 16 | -30 | -7 |
Investing Cash Flow Investing Cash FlowCr | -3 | 0 | -4 | -1 | -1 | -47 | -16 | 25 |
Financing Cash Flow Financing Cash FlowCr | 2 | -1 | -1 | 0 | -3 | 33 | 44 | -18 |
|
Free Cash Flow Free Cash FlowCr | -2 | 2 | 3 | 0 | 3 | -5 | -47 | -8 |
| -1,879.2 | -2,578.4 | 738.0 | -2.3 | 92.6 | 135.7 | -291.2 | 110.4 |
CFO To EBITDA CFO To EBITDA% | 126.0 | 389.4 | 214.7 | -5.2 | 60.7 | 94.0 | -129.5 | -107.7 |
| Financial Year | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 3 | 22 | 104 | 193 | 224 | 65 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 3.8 | 0.0 | 23.5 | 22.2 | 35.1 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.1 | 1.0 | 1.7 | 1.2 | 1.4 | 0.5 |
Price To Book Price To Book | 0.0 | 0.0 | 11.9 | 1.1 | 4.3 | 4.4 | 3.5 | 0.9 |
| 2.8 | 1.5 | 5.5 | -7.4 | 18.0 | 15.1 | 14.3 | 32.2 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 34.9 | 25.2 | 33.3 | 37.3 | 41.6 | 36.4 |
| 1.8 | 0.7 | 5.6 | -23.5 | 11.0 | 10.6 | 14.1 | 4.8 |
| -0.1 | -0.1 | 1.6 | -53.2 | 7.2 | 7.3 | 6.3 | -4.7 |
| 7.2 | 6.4 | 14.0 | -26.2 | 14.7 | 15.6 | 11.9 | 2.9 |
| -1.3 | -1.9 | 318.3 | -56.9 | 18.4 | 26.9 | 16.5 | -8.8 |
| -0.5 | -0.5 | 1.6 | -28.0 | 8.6 | 7.7 | 4.5 | -2.3 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **1. Company Overview**
**Indrayani Biotech Limited (IBL)** is a diversified Indian conglomerate operating across multiple high-growth sectors including **Food & Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture, and Infrastructure**. Originally focused on biotechnology, IBL has strategically transformed into a multi-sector holding company through the **aggregation of high-potential MSMEs**, integrating them into a unified corporate ecosystem while preserving their entrepreneurial leadership.
The company follows a **"brownfield aggregation" model**, acquiring established, independently managed MSMEs and providing them with financial, operational, compliance, and strategic support, enabling rapid scalability and enhanced value realization. IBL ensures **aligned growth** by allowing original promoters to retain management control while adding board oversight from the listed parent entity.
---
### **2. Business Model & Strategy**
- **MSME Aggregation Strategy**: Since 2021, IBL has systematically aggregated successful MSMEs across sectors, starting with Helios Solutions (2018), A-Diet Express (2018), and Nandhini Biotech (2020). The goal is to unlock latent potential through **capital infusion, shared services, and operational synergy**, with future monetization pathways via SME exchanges.
- **Inclusive & Win-Win Structure**: Subsidiaries retain promoter ownership and leadership. IBL provides corporate governance, compliance, access to capital, and centralized functions, ensuring stability and scalability.
- **Centralized Ecosystem Support**:
- Shared infrastructure in **Finance, HR, Legal, IT, and Secretarial services** reduces overheads.
- Encourages **knowledge sharing, technology repurposing, and cross-functional collaboration**.
- Subsidiaries can **procure raw materials and sell outputs within the group**, boosting internal demand and value realization.
- **Growth through Inorganic Expansion**: IBL actively pursues **acquisitions and strategic partnerships**, particularly in the healthcare, dairy, and power electronics sectors.
---
### **3. Key Subsidiaries & Business Verticals**
#### **A. Healthcare & Pharma – IBL Healthcare Limited**
- **Established**: October 2020; fully acquired by IBL in March 2022.
- **Focus**: Integrated healthcare solutions via **single-specialty clinics, hospital partnerships, pharma marketing, manufacturing, and medical equipment**.
- **Acquisitions**:
- **Healthway India Pvt Ltd** (pharma marketing).
- **Kniss Laboratories Pvt Ltd** (GMP-certified pharma manufacturing, ISO 9001).
- **Peekay Mediequip** (manufacturer of needles, syringes, IV sets).
- **Vaasan Medical Center** (pharmacy retail chain).
- **Clinical Services**:
- IBL Eyecare Clinic (Tiruvannamalai).
- Nalam Multispeciality Dental Hospital (Chennai).
- LA FUSE Hair & Skin Clinic (Chennai).
- **Strategy**: Hub-and-spoke model with urban hospitals acting as hubs and OP clinics as feeders. Plans to expand service offerings nationwide.
- **R&D & Marketing**:
- Launching branded **allopathic, Ayurvedic, and nutraceutical products** under 'Healthway'.
- Proprietary developments include CELNORM (onco-nutrition), ARLIN (arthritis), Loparet (GI health), and HERCOF (herbal cough syrup).
- **Export Ambitions**: Products exported to East Europe, Middle East, and Southeast Asia; scaling up international footprint.
#### **B. Food & Hospitality – A-Diet Express Hospitality Service**
- **Established**: 2002; merged with IBL in April 2018.
- **Services**: Contract catering for **corporate offices, IT parks, hospitals, educational institutions**, and **food courts under 'Nalla Sappadu'**.
- **Scale**:
- Operates across **12 states, 20+ cities**, serving **over 100,000 meals daily**.
- Two central kitchens (combined 50,000 meals/day), multiple onsite kitchens.
- Clients include **IIT Roorkee (₹12 Cr contract), Gautam Buddha University (₹8 Cr)**.
- **Facilities**:
- New **central kitchen in Poonamallee (Chennai)**, equipped with **touch-free, energy-efficient technology**.
- ISO 9001 & ISO 22000 certified.
- **Market Opportunity**: Part of India’s ₹6.6 lakh crore food services sector (10–11% CAGR), with strong momentum in institutional catering.
#### **C. Dairy – Dindigul Farm Products Pvt Ltd & A.R. Dairy**
- **Brands**: *EnNutrica* (dairy proteins), *Raaj Milk*, *Malabar*.
- **Facilities**:
- 19-acre plant in Dindigul; 17-acre facility.
- Combined processing capacity: **300,000 liters/day**.
- Produces **milk protein concentrate, casein, whey powder, SMP, WMP, dairy whiteners, curd, ghee**.
- **Capacity**: 60 tons/month of protein-based products; turnover of **₹200+ crores annually**.
- **Sustainability**: ~80–100% renewable energy use.
- **Direct Sourcing**: Expanding procurement directly from farmers via digital payments to improve margins and farmer engagement.
- **Market Outlook**: Indian dairy protein market valued at **₹5,500 Cr (2023)**, growing at **10% CAGR**; high export demand for casein and protein concentrates.
#### **D. Engineering**
1. **Matrix Boilers Private Limited**
- **Established**: 2006; acquired/revived by IBL.
- **Product Range**: Industrial boilers (2–50 TPH), waste heat recovery, economizers, pressure vessels.
- **Technology**: Holds a **patented HYBRID boiler design** that reduces fuel/power consumption by 15–20%.
- **Global Footprint**: Over 450 boilers supplied in **India, Sri Lanka, Myanmar, Bangladesh, Africa**.
- **Key Projects**: Empaneled as supplier of boiler shells for **Southern Railway’s T Engine steam locomotive project**.
- **Facility**: Two units on 4-acre land in Mathur, Tiruchirappalli.
2. **Helios Solutions Limited** (now merged with IBL)
- **Founded**: 1995; merged in 2018.
- **Core Business**: Design, manufacturing, and service of **industrial UPS systems, battery chargers, inverters, voltage stabilizers, and special-purpose machines**.
- **Defense & Space Clients**:
- Supplied **2x25 kW modular power systems for Indian Navy submarines**.
- Provided **pyro control consoles for ISRO/DRDO satellite launch facilities**.
- Critical power systems for **Chennai Port Trust, ISRO, Indian Navy, DRDO**.
- **Innovations**:
- Developed India’s first **Automatic Rescue Device for elevators (ARD)** – over **15,000 units installed**.
- Piloted **50 electric garbage collection vehicles (ePIC)** for Chennai Corporation with **1-year successful operation**.
- **Global Presence**: Installations in **Spain, South Africa, UAE, Thailand, Italy**.
- **Partnerships**: 20+ year alliances with **Gammatronic (Israel)** and **Gewiss (Italy)**.
#### **E. Biotechnology & Agri**
- **Core Activities**:
- Manufactures **biofertilizers** (Pseudomonas, Trichoderma viride), **biopesticides**, **vermicompost**, **neem-based products**, **VAM**.
- Offers **turnkey consultancy** in agriculture, aquaculture, horticulture, tissue culture, soil/water testing, and nursery development.
- **R&D & Facilities**:
- Advanced labs in **Ponneri (Chennai)** and **Sirumugai (Coimbatore)**.
- New **2-acre biotech plant** in Sirumugai for bio-fortified vermicompost and coir pith.
- **Integration**:
- Supplies inputs to **HSL Agri Solutions’ 100-acre organic farm**.
- Products used in internal dairy and food production; also sold commercially.
- **Brand Integration**: Merger with **Nandhini Biotech (2020)** accelerated product portfolio and market reach.
#### **F. Agriculture & Agro-Processing – HSL Agri Solutions**
- **Land**: ~100 acres (owned & leased).
- **Functions**:
- Backward integration for **A-Diet**; forward integration with **Biotech**.
- Cultivates **organic vegetables, fruits, groceries** using bio-inputs, as per A-Diet demand forecasts.
- Sources & procures bulk groceries; trades surplus stock.
- **Milestone Acquisition**: Acquired **Dilasa Agro Processors Pvt Ltd (2024)**, an agro-processing unit in Aurangabad.
- **Operations**: 2-acre facility processing dal (tur, channa), tomato ketchup/puree, mango pulp, bakery items (Nutri Bakes), and cattle feed.
- **Brands**: Baliraja, Mr. Tom, Tasty Tom, Aamra.
- **Farmer Integration**: Uses **Farmer Producer Organizations (FPOs)** to eliminate middlemen.
#### **G. Infrastructure – HSLPrime Properties Pvt Ltd**
- **Founded**: 2017; real estate and infrastructure arm.
- **Projects**:
- **Desavani Towers**: 44,000 sq ft Class A commercial building in **Guindy, Chennai**.
- Pipeline: More commercial, residential, and **DTCP-approved plots (up to 50 acres)**.
- **Concept Developments**:
- Farm lands with **"Work from Farm"** models for IT professionals and HNIs.
- Green housing for retirees, supported by **agro division for centralized farm management**.
- **Collaborative Model**: Integrates with Agro division for sustainable land use and value creation.
#### **H. Finance & CSR**
- **IBL Investments**: Provides financial support and working capital funding to subsidiaries.
- **IBL Social Foundation**: Handles corporate social responsibility initiatives.
---
### **6. Key Dates & Milestones Summary**
| Year | Milestone |
|------|-----------|
| **2018** | Merger with Helios Solutions and A-Diet Express Hospitality. |
| **2020** | Launch of IBL Healthcare; integration of Nandhini Biotech. |
| **2021–2023** | Aggregation strategy launched; multiple acquisitions in pharma, agro, and real estate. |
| **2022–2024** | Kniss Laboratories, Healthway India, Dilasa Agro acquired. IBL Dairy listed on BSE SME. |
| **2024–2025** | Expansion of central kitchens, hospital partnerships, ePIC vehicles, solar projects. Desavani Towers under construction. |
| **Sep 2025** | Strengthening of group ecosystem, centralized governance, and focus on scalable MSME integration. |